Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C18H16N4 |
| Molecular Weight | 288.3464 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC2=C(N1)C=C(C=C2)C(N3C=CN=C3)C4=CC=CC=C4
InChI
InChIKey=DCGOMTSIZLGUOK-UHFFFAOYSA-N
InChI=1S/C18H16N4/c1-13-20-16-8-7-15(11-17(16)21-13)18(22-10-9-19-12-22)14-5-3-2-4-6-14/h2-12,18H,1H3,(H,20,21)
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A new uricosuric substance 5-[(1H-imidazol-1-yl)phenylmethyl]-2-methyl-1H-benzimidazole (C18H16N4). | 1989 Jun 15 |
|
| Rapid onset of uricosuria after oral administration of irtemazole, an uricosuric substance. | 1989 Oct 17 |
|
| Uricosuric effect of irtemazole in healthy subjects. | 1989 Oct 2 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ZPE7CM7FNG
Created by
admin on Sat Dec 16 10:17:51 GMT 2023 , Edited by admin on Sat Dec 16 10:17:51 GMT 2023
|
PRIMARY | |||
|
115576-85-7
Created by
admin on Sat Dec 16 10:17:51 GMT 2023 , Edited by admin on Sat Dec 16 10:17:51 GMT 2023
|
PRIMARY | |||
|
71330
Created by
admin on Sat Dec 16 10:17:51 GMT 2023 , Edited by admin on Sat Dec 16 10:17:51 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
